The Latest: Australia has 2nd likely Astra-Zeneca clot case
CANBERRA, Australia — Australian authorities have identified a second case of a rare blot clot likely linked to the AstraZeneca coronavirus vaccine.
Officials said Tuesday the woman is in her 40s and is in a stable condition. A 44-year-old man developed the same condition following an AstraZeneca injection March 22.
Australia has administered 700,000 doses of the AstraZeneca vaccine since early March. That equates to a clotting frequency of 1-in-350,000 cases. British authorities say the risk of such blood clots has been 1-in-250,000 in that country.
Australia had planned to rely on Australian-manufactured AstraZeneca for delivering at least one dose of a vaccine to all eligible adults among its population of 26 million by October. But it said last week the Pfizer vaccine is now the preferred option for people under 50 because of the potential risk from AstraZeneca.
THE VIRUS OUTBREAK:
VACCINES: More than 120.8 million people, or 36.4% of the U.S. population, have received at least one dose of a coronavirus vaccine, according to the Centers for Disease Control and Prevention. Some 74 million people, or 22% of the population, have completed their vaccination.
CASES: The seven-day rolling average for daily new cases in the U.S. rose over the past two weeks from 63,236 on March 28 to 70,040 on Sunday, according to Johns Hopkins University.
DEATHS: The seven-day rolling average for daily new deaths in the U.S. did not increase over the past two weeks from 975 on March 28 to 969 on Sunday, according to Johns Hopkins University.
— Muslims are navigating coronavirus regulations for their second Ramadan in the shadow of the pandemic
— China's top disease control official said current vaccines offer low protection, mixing them is among strategies being considered to...